3,4-Methylenedioxy-N-propargylamphetamine

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
3,4-Methylenedioxy-N-propargylamphetamine
MDPL.png
Names
IUPAC name
N-[1-(1,3-Benzodioxol-5-yl)propan-2-yl]prop-2-yn-1-amine
Identifiers
  • 74698-46-7
3D model (JSmol)
  • Interactive image
ChemSpider
  • 21106336
Properties
C13H15NO2
Molar mass 217.27 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references

3,4-Methylenedioxy-N-propargylamphetamine (MDPL) is a lesser-known psychedelic drug and a substituted amphetamine. MDPL was first synthesized by Alexander Shulgin. In his book PiHKAL (Phenethylamines i Have Known And Loved), the minimum dosage is listed as 150 mg, and the duration unknown.[1] MDPL causes few to no effects. Very little data exists about the pharmacological properties, metabolism, and toxicity of MDPL.

Legality

United Kingdom

This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act.[2]

See also

References

  1. ^ MDPL entry in PiHKAL
  2. ^ "UK Misuse of Drugs act 2001 Amendment summary". Isomer Design. Retrieved 12 March 2014.


Retrieved from "https://en.wikipedia.org/w/index.php?title=3,4-Methylenedioxy-N-propargylamphetamine&oldid=846480836"
This content was retrieved from Wikipedia : http://en.wikipedia.org/wiki/3,4-Methylenedioxy-N-propargylamphetamine
This page is based on the copyrighted Wikipedia article "3,4-Methylenedioxy-"; it is used under the Creative Commons Attribution-ShareAlike 3.0 Unported License (CC-BY-SA). You may redistribute it, verbatim or modified, providing that you comply with the terms of the CC-BY-SA